• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Carbocyclic fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Carbocyclic fatty acids

Recent Advances in the Study of 3-Cyclohexyl-2-methylpropanoic Acid (CAS: 186900-67-4) in Chemical Biology and Pharmaceutical Research

3-Cyclohexyl-2-methylpropanoic acid (CAS: 186900-67-4) is a chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its cyclohexyl and methylpropanoic acid moieties, has been explored for its unique physicochemical properties and biological activities. Recent studies have focused on its synthesis, structural modifications, and potential therapeutic applications, making it a subject of interest for researchers in the field.

One of the key areas of research involving 3-Cyclohexyl-2-methylpropanoic acid is its role as a building block in the synthesis of more complex molecules. Recent publications have highlighted its utility in the development of novel drug candidates, particularly in the context of anti-inflammatory and antimicrobial agents. For instance, a 2023 study published in the *Journal of Medicinal Chemistry* demonstrated that derivatives of 3-Cyclohexyl-2-methylpropanoic acid exhibited potent inhibitory effects against specific bacterial strains, suggesting its potential as a scaffold for antibiotic development.

In addition to its antimicrobial properties, 3-Cyclohexyl-2-methylpropanoic acid has also been investigated for its potential in modulating metabolic pathways. A recent preprint on *bioRxiv* reported that this compound could interact with key enzymes involved in lipid metabolism, offering insights into its possible use in treating metabolic disorders such as obesity and diabetes. The study utilized advanced computational modeling and in vitro assays to elucidate the compound's mechanism of action, providing a foundation for future in vivo studies.

Another notable advancement in the study of 3-Cyclohexyl-2-methylpropanoic acid is its application in chemical biology as a probe for understanding protein-ligand interactions. Researchers have employed this compound to study the binding affinities and conformational changes of target proteins, as detailed in a 2022 paper in *ACS Chemical Biology*. The findings from such studies are critical for the rational design of new therapeutics and the optimization of existing drug candidates.

Despite these promising developments, challenges remain in the widespread application of 3-Cyclohexyl-2-methylpropanoic acid. Issues such as bioavailability, toxicity, and scalability of synthesis need to be addressed in future research. However, the compound's versatility and the growing body of evidence supporting its biological activities make it a valuable candidate for further exploration. Ongoing studies are expected to shed more light on its full potential in drug discovery and chemical biology.

In conclusion, 3-Cyclohexyl-2-methylpropanoic acid (CAS: 186900-67-4) represents a promising area of research in the chemical biology and pharmaceutical fields. Its diverse applications, from antimicrobial agents to metabolic modulators, highlight its significance as a multifunctional compound. As research continues to uncover its mechanisms and optimize its properties, this compound is poised to play a pivotal role in the development of next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)